Heart Disease News and Research

Latest Heart Disease News and Research

New study on incidence of breast cancer in Italy

A new study on the incidence of breast cancer in Italy has been published in the International Journal of Experimental and Clinical Cancer Research.

1 Dec 2012

Caregiving associated with increased cardiovascular disease risk

People acting as caregivers for family members with cardiovascular disease may inadvertently increase their own risk for heart disease by neglecting their own health, according to a new study in the American Journal of Health Promotion.

1 Dec 2012

Respiratory physical therapy before cardiac surgery may reduce serious pulmonary complications

Patients who practice respiratory physical therapy exercises before elective cardiac surgery may reduce serious pulmonary complications later, finds a new evidence review from The Cochrane Library.

30 Nov 2012

Asthma and nasal congestion common insomnia triggers

Insomnia is a common problem in patients with asthma, suggests research published in Allergy.

30 Nov 2012

Air quality in cities linked to inflammatory risk in diabetes

Exposure to traffic-related air pollutants is associated with a rapid increase in systemic inflammation in patients with diabetes, report Indian researchers.

30 Nov 2012

Topical simvastatin may be answer to nonhealing diabetic wounds

Topical simvastatin significantly accelerates wound healing in mice and may be a good treatment option for diabetic patients with nonhealing wounds, say researchers.

30 Nov 2012

Poor empathy may feature in common psychiatric conditions

Individuals with schizophrenia, bipolar disorder, or depression may be less empathic than individuals without these conditions, according to German study results.

30 Nov 2012

Evidence of neurobiologic differences between bipolar subtypes

Taiwanese researchers have found differences in fronto-limbic metabolism and executive function between patients with bipolar disorder I and II.

30 Nov 2012

Physicians beware of fruity drug interactions

An understanding of the potential for pharmacokinetic interaction between orally administered drugs and grapefruit is necessary in view of an increase in marketed medications that fit the risk criteria, suggest Canadian researchers.

30 Nov 2012

Coronary artery bypass grafting safe for dialysis patients

Among the two available procedures for opening blocked arteries surrounding the heart, one appears to be safer than the other for dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

30 Nov 2012

BMBF to provide EUR 1.3M to develop MRI using polarized substances

Over the past 30 years, magnetic resonance imaging has evolved into one of the most important imaging procedures in medical diagnostics. With a new approach based on the use of polarized gases and dissolved substances, it will in future be possible to produce even better quality images of the inside of the human body.

30 Nov 2012

Exposure to essential oil for 1 hour would be effective in reducing heart rate and blood pressure

The scents which permeate our health spas from aromatic essential oils may provide more benefits than just a sense of rest and well-being.

30 Nov 2012

How technology is introducing new twists into health privacy protections

The U.S. has strict privacy laws guaranteeing people access to traditional health files. But implants and other new technologies - including smartphone apps and over-the-counter monitors - are testing the very definition of medical records.

From Medtronic 30 Nov 2012

Eisai announces FDA acceptance of AcipHex NDA for priority review

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.

30 Nov 2012

Two Sanford-Burnham projects win International Space Station Research Competition

Sanford-Burnham Medical Research Institute (Sanford-Burnham) today announced that two of the Institute's research teams have won Space Florida's International Space Station (ISS) Research Competition. Eight teams were selected from a pool of international applicants to send experiments to space in late 2013.

30 Nov 2012

Study: Controversial treatment for autism spectrum disorder may be harmful

A controversial treatment for autism spectrum disorder (ASD) is not only ineffective but may be harmful, according to a study conducted by Baylor University researchers.

30 Nov 2012

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis will highlight more than 140 presentations on key data from its extensive oncology portfolio at the leading year-end scientific meetings devoted to hematology and breast cancer, demonstrating continued innovation in research and development efforts to advance the care of patients with cancer and rare diseases.

30 Nov 2012

Cleveland Clinic researcher names American Association for the Advancement of Science Fellow

Cleveland Clinic researcher Jun Qin, Ph.D., has been named a Fellow of the American Association for the Advancement of Science (AAAS). As part of the Molecular Cardiology Department in the Lerner Research Institute, Qin was elected as an AAAS Fellow for exemplary contributions to the field of cell signaling.

30 Nov 2012

Pivotal Therapeutics reports loss of $811,164 for third quarter 2012

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on cardiovascular disease and overall health today announced its financial results and operational highlights for the quarter ended September 30, 2012. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated.

30 Nov 2012

University of Cincinnati to lead Belatacept Early Steroid withdrawal Trial

The University of Cincinnati will lead a $5.2 million national trial studying removal of both corticosteroids and common immunosuppression treatments from the post-transplant drug regimen for kidney transplant patients.

29 Nov 2012